G. Brenning
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Lymphatic System and Diseases
- Cancer Treatment and Pharmacology
- Cytokine Signaling Pathways and Interactions
Papers in
- Hematology 13
- Multiple Myeloma Research and Treatments 13
- Oncology 8
- Peptidase Inhibition and Analysis 4
- Lymphatic System and Diseases 2
- Co-authors
- A. Åhre (7 shared papers)Bengt Simonsson (5 shared papers)Kenneth Nilsson (3 shared papers)Shahin Abdsaleh (2 shared papers)Clas F. R. Källander (3 shared papers)Gösta Gahrton (5 shared papers)Magnus Björkholm (4 shared papers)Hans Gyllenhammar (3 shared papers)
In The Last Decade
G. Brenning
21 papers receiving 483 citations
Peers
Comparison fields: 5 of 65
- Hematology 298
- Oncology 284
- Genetics 74
- Pathology and Forensic Medicine 58
- Immunology 64
Countries citing papers authored by G. Brenning
This map shows the geographic impact of G. Brenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Brenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Brenning more than expected).
Fields of papers citing papers by G. Brenning
This network shows the impact of papers produced by G. Brenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Brenning. The network helps show where G. Brenning may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Brenning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 78 | |
| 2 | 1985 | 54 | |
| 3 | Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden. | 1984 | 46 |
| 4 | 2001 | 40 | |
| 5 | 1985 | 37 | |
| 6 | 1985 | 34 | |
| 7 | 1987 | 33 | |
| 8 | 2001 | 33 | |
| 9 | 2007 | 24 | |
| 10 | 1986 | 23 | |
| 11 | 1986 | 22 | |
| 12 | 1983 | 21 | |
| 13 | 1988 | 16 | |
| 14 | 2005 | 12 | |
| 15 | 1975 | 11 | |
| 16 | 1985 | 10 | |
| 17 | 1993 | 3 | |
| 18 | 1987 | 2 | |
| 19 | 1988 | 1 | |
| 20 | 1976 | 1 |
About G. Brenning
G. Brenning is a scholar working on Hematology, Oncology, Molecular Biology, Surgery and Genetics, having authored 21 papers that have together received 502 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Peptidase Inhibition and Analysis (4 papers), Phytochemical compounds biological activities (3 papers), Glycosylation and Glycoproteins Research (3 papers), Lymphatic System and Diseases (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Research on Leishmaniasis Studies (2 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers). The work is most often cited by research in Hematology (298 citations), Oncology (284 citations), Genetics (74 citations), Pathology and Forensic Medicine (58 citations) and Immunology (64 citations). G. Brenning has collaborated with scholars based in Sweden and Canada. Frequent co-authors include A. Åhre, Bengt Simonsson, Kenneth Nilsson, Shahin Abdsaleh, Clas F. R. Källander, Gösta Gahrton, Magnus Björkholm, Hans Gyllenhammar, A. Killander and Kristina Carlson. Their work appears in journals such as British Journal of Haematology, European Journal Of Haematology, Acta Radiologica, European Journal of Clinical Pharmacology and European Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.